As indicated previously, SALL1, SALL2, and SALL3 hypermethylation are associated with bad prognosis in several cancers [54,55,92,93,94,95,96,97], and the epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer [54]. Here, SALL2 is linked to cancer.